Cargando…
A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS
Loss of TAR DNA-binding protein 43 kDa (TDP-43) splicing repression is well-documented in postmortem tissues of amyotrophic lateral sclerosis (ALS), yet whether this abnormality occurs during early-stage disease remains unresolved. Cryptic exon inclusion reflects functional loss of TDP-43, and thus...
Autores principales: | Irwin, Katherine E., Jasin, Pei, Braunstein, Kerstin E., Sinha, Irika, Bowden, Kyra D., Moghekar, Abhay, Oh, Esther S., Raitcheva, Denitza, Bartlett, Dan, Berry, James D., Traynor, Bryan, Ling, Jonathan P., Wong, Philip C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928052/ https://www.ncbi.nlm.nih.gov/pubmed/36789434 http://dx.doi.org/10.1101/2023.01.23.525202 |
Ejemplares similares
-
Elevated nuclear TDP-43 induces constitutive exon skipping
por: Carmen-Orozco, Rogger P., et al.
Publicado: (2023) -
Tdp-43 cryptic exons are highly variable between cell types
por: Jeong, Yun Ha, et al.
Publicado: (2017) -
Quantitative analysis of cryptic splicing associated with TDP-43 depletion
por: Humphrey, Jack, et al.
Publicado: (2017) -
The N-terminal dimerization is required for TDP-43 splicing activity
por: Jiang, Lei-Lei, et al.
Publicado: (2017) -
Phase separation-deficient TDP43 remains functional in splicing
por: Schmidt, Hermann Broder, et al.
Publicado: (2019)